Pirfenidone Capsule, 267 mg

FDA Drug Profile — Pirfenidone Capsule, 267 mg

Drug Details

Generic Name
Pirfenidone Capsule, 267 mg
Brand Names
Pirfenidone Capsule, 267 mg
Application Number
ANDA212748
Sponsor
Macleods Pharmaceuticals Limited
NDC Codes
1
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
PIRFENIDONE

Indications and Usage

1 INDICATIONS AND USAGE Pirfenidone capsules are indicated for the treatment of idiopathic pulmonary fibrosis (IPF). Pirfenidone capsules are a pyridone indicated for the treatment of idiopathic pulmonary fibrosis (IPF). ( 1 )